Thomas Jefferson UniversityJefferson School of Population Health

Main menu:

Outcomes Research Fellow Publications

References

  • Crawford AG, Cote C, Couto J, Daskiran M, Gunnarsson C, Haas K, Haas S, Nigam SC, Schuette R. Prevalence of obesity, type II diabetes mellitus, hyperlipidemia, and hypertension in the united states: Findings from the GE centricity electronic medical record database. Popul Heath Manage 2010; 13(3):151-61.
  • Crawford AG, Cote C, Couto J, Daskiran M, Gunnarsson C, Haas K, Haas S, Nigam SC, Schuette R, Yaskin J. Comparison of GE centricity electronic medical record database and national ambulatory medical care survey findings on the prevalence of major conditions in the united states. Popul Heath Manage 2010; 13(3):139-50.
  • Jacoby R, Crawford AG, Chaudhari P, Goldfarb NI. Quality of care for 2 common pediatric conditions treated by convenient care providers. American Journal of Medical Quality 2010.
  • Lee E, Goldfarb NI. Literature review. American Journal of Medical Quality 2010; 25(4):322-4.
  • Maio V, Canale SD, Abouzaid S, GAP Investigators. Using explicit criteria to evaluate the quality of prescribing in elderly italian outpatients: A cohort study. J Clin Pharm Ther 2010; 35(2):219-29.
  • Mohandas A, Goldfarb NI. Literature review. American Journal of Medical Quality 2010; 25(1):76-7.
  • Richardson DM, Bain KT, Diamond JJ, Novielli KD, Lee SP, Goldfarb NI. Effectiveness of guideline-recommended cardiac drugs for reducing mortality in the elderly medicare heart failure population: A retrospective, survey-weighted, cohort analysis. Drugs Aging 2010;27(10):845-54.
  • Slabaugh SL, Goldfarb NI. Literature review. American Journal of Medical Quality 2010; 25(3):232-3.
  • Abouzaid S. Book review: Global health and global aging. Health Policy Newsletter 2009; 22(2):13.
  • Abouzaid S, Couto JE, Royo MB. 58th annual meeting american society of human genetics. P T 2009; 34(2):92-3.
  • Abouzaid S, Goldfarb NI. Literature review. American Journal of Medical Quality 2009; 24(2):169-71.
  • Abouzaid S, Maio V. The inequality in health care quality. American Journal of Medical Quality 2009; 24(3):182-4.
  • Couto JE, Romney MC, Leider HL, Sharma S, Goldfarb NI. High rates of inappropriate drug use in the chronic pain population. Popul Heath Manage 2009; 12(4):185-90.
  • Couto JE, Webster L, Romney MC, Leider HL, Linden A. Use of an algorithm applied to urine drug screening to assess adherence to an OxyContin® regimen. J Opioid Manage 2009; 5(6):359-64.
  • Couto J, Goldfarb NI. Literature review. American Journal of Medical Quality 2009; 24(1):79-81.
  • Duh MS, Paradis P, LatremouilleViau D, Greenberg PE, Lee SP, Durkin MB, Wan GJ, Rupnow MFT, LeLorier J. The risks and costs of multiple-generic substitution of topiramate SYMBOL. Neurology 2009 June 16; 72(24):2122-9.
  • Gagne JJ, Maio V. Comment: Pharmaceutical care for migraine and headache patients: A community-based, randomized intervention. Ann Pharmacother 2009; 43(3):550-1.
  • Pizzi LT, Talati A, Gemmen E, Dahl NV, Bunz TJ, Sand PK. Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: Results from the MATRIX study. Pharmacoeconomics 2009; 27(4):329-39.
  • Chaudhari P. Impact of rheumatoid arthritis and biologics on employers and payers. Biotechnology Healthcare July/August 2008.
  • Chaudhari PK, Goldfarb NI. Literature review. American Journal of Medical Quality May/June 2008; 23(3):234-6.
  • Gagne JJ, Maio V, Berghella V, Louis DZ, Gonnella JS. Prescription drug use during pregnancy: A population-based study in regione emilia-romagna, italy. Eur J Clin Pharmacol 2008; 64(11):1125-32.
  • Gagne JJ, Maio V, Rabinowitz C. Prevalence and predictors of potential drug-drug interactions in regione emilia-romagna, italy. J Clin Pharm Ther 2008; 33(2):141-51.
  • Hess G, Hill J, Lau H, Dastani H, Chaudhari P. Medication utilization patterns and hypertension-related expenditures among patients who were switched from fixed-dose to free-combination antihypertensive therapy. P T 2008; 33(11):652-66.
  • Leas BF, Gagne JJ, Goldfarb NI, Rupnow MF, Silberstein S. Assessing quality of care for migraineurs: A model health plan measurement set. Popul Health Manag 2008; 11(4):203-8.
  • Gagne JJ, Goldfarb NI. Candidemia in the in-patient setting: Treatment options and economics. Expert Opin Pharmacother 2007 08/01; 8(11):1643-50.
  • Gagne JJ, Leas B, Lofland JH, Goldfarb N, Freitag F, Silberstein S. Quality of care measures for migraine: A comprehensive review. Disease Management 2007 06/01; 10(3):138-46.
  • Lee SP, Gagne JJ. A burgeoning opportunity for future pharmacists. Student Pharmacists 2007; 2(3):19.
  • Lee SP, Bain KT, Maio V. Appropriate discontinuation of medications at the end of life: A need to establish consensus criteria. American Journal of Medical Quality 2007; 22(6):393-4.
  • Lee SP, Clarke JL. Literature review. American Journal of Medical Quality 2007; 22(3):218-20.
  • Lofland JH, Gagne JJ, Pizzi LT, Rupnow M, Silberstein SD. Impact of topiramate migraine prophylaxis on workplace productivity: Results from two US randomized, double-blind, placebo-controlled, multicenter trials. Journal of Occupational & Environmental Medicine 2007 March; 49(3):252-7.
  • Gagne JJ. Literature review. Value Based Purchasing 2006; 1(2):10-2.
  • Gagne JJ. Literature review. Value Based Purchasing 2006; 1(1):7-8.
  • Gagne JJ, Breithart RE, Maio V, Horn DL, Hartmann CW, Swanson R, Goldfarb NI. Costs associated with candidemia in a hospital setting. P T 2006; 31(10).
  • Gagne JJ, Singh M, Talati AR. Manifestation of adult attention-deficit/hyperactivity disorder available treatment options. P T 2006; 31(12):736-41.
  • Gagne J, Goldfarb NI. Literature review. American Journal of Medical Quality 2006; 21(3):210-2.
  • Lee SP. Jeff-ISPOR student chapter chartered out of department of health policy. Health Policy Newsletter 2006; 19(4).
  • Maio V, Hartmann CW, Poston S, Liu-Chen X, Diamond J, Arenson C. Potentially inappropriate prescribing for elderly patients in 2 outpatient settings. American Journal of Medical Quality 2006; 21(3):162-8.
  • Pizzi LT, Patel NM, Maio VM, Goldfarb DS, Michael B, Fuhr JP, Goldfarb NI. Economic implications of non-adherence to treatment recommendations for hemodialysis patients with anemia. Dialysis & Transplantation 2006; 35(11):660-71.
  • Talati AR, Maio V, Hartmann CW. Quality prescribing for the elderly. Medicare Patient Management 2006:34-7.
  • Talati A, Goldfarb NI. Literature review. American Journal of Medical Quality 2006; 21(4):280.
  • Brophy DF, Ripley EB, Kockler DR, Lee S, Proeschel LA. Darbepoetin alfa therapeutic interchange protocol for anemia in dialysis. Ann Pharmacother 2005 November 1; 39(11):1808-11.
  • Crawford AG, Sikirica V, Goldfarb N, Popiel RG, Patel M, Wang C, Chu JB, Nash DB. Interactive voice response reminder effects on preventive service utilization. Am J Med Qual 2005; 20(6):329-36.
  • Goldfarb NI, Patel NM, Clarke JL. Improving quality by encouraging providers to use pediatric combination vaccines. Manag Care 2005; 14(6 Suppl):3-12.
  • Patel NM, Goldfarb NI. Literature review. American Journal of Medical Quality 2005; 20(4):222-4.
  • Pizzi LT, Carter CT, Howell JB, Vallow SM, Crawford AG, Frank ED. Work loss, healthcare utilization, and costs among US employees with chronic pain. Dis Manage Health Outcomes 2005; 13(3):201-8.
  • Poston S, Goldfarb NI. Literature review. American Journal of Medical Quality 2005; 20(3):167-9.
  • Salvador CG, Sikirica M, Evans A, Pizzi L, Goldfarb N. Clinical and economic outcomes of prolonged postoperative ileus in patients undergoing hysterectomy and hemicolectomy. P T 2005; 30(10):590-5.
  • Goldfarb NI, Pizzi LT, Fuhr Jr. JP, Salvador C, Sikirica V, Kornbluth A, Lewis B. Diagnosing crohn's disease: An economic analysis comparing wireless capsule endoscopy with traditional diagnostic procedures. Dis Manage 2004; 7(4):292-304.
  • Goldfarb N, Weston C, Hartmann CW, Sikirica M, Crawford A, He H, Howell J, Maio V, Clarke J, Nuthulaganti B, Cobb N. Impact of appropriate pharmaceutical therapy for chronic conditions on direct medical costs and workplace productivity: A review of the literature. Disease Management 2004 03/01; 7(1):61-75.
  • Sikirica V. The national medicare prescription drug congress. P T 2004; 29(4):223-6.
  • Carter C, Goldfarb NI, Hartmann CW, Roumm AR, Vallow SM, Durkin M. Chronic pain management in managed care organizations: A national survey of medical directors. P T 2003; 28(3):179,184-215.
  • Goldfarb NI, Maio V, Carter CT, Pizzi L, Nash DB. How does quality enter into health care purchasing decisions? Issue Brief (Commonw Fund) 2003(635):1-8.
  • Maio V, Belazi D, Goldfarb NI, Phillips AL, Crawford AG. Use and effectiveness of pharmacy continuing-education materials. Am J Health-Syst Pharm 2003; 60(16):1644-9.
  • Maio V, Lofland JH, Doan Q, Duttagupta S, Khan ZM, Phillips AL, Sansgiry SS, Shah AB, Sung J, Yokoyama K. Organizational structure and educational components of pharmacoeconomic fellowship programs: A fellows' perspective. Am J Pharm Educ 2003; 67(4).
  • Sikirica V. Demonstrating the business value of good health: The institute for health and productivity management's academy. P T 2003; 28(12):797-8.
  • Belazi D. Measuring health status and quality of life in disease management programs. Dis Manage 2002; 5(1):61-7.
  • Belazi D, Goldfarb NI, He H. Measuring health-related quality of life in the clinical setting. Expert Rev Pharmacoecon Outcomes Res 2002; 2(2):109-17.
  • Girts TK, Crawford AG, Goldfarb NI, Bachleda M, Grogg A. Predicting high utilization of emergency department services among patients with a diagnosis of psychosis in a medicaid managed care organization. Disease Management 2002; 5(4):189-96.
  • Goldfarb NI, Phillips A, Conn M, Lewis BS, Nash DB. Economic and health outcomes of capsule endoscopy: Opportunities for improved management of the diagnostic process for obscure gastrointestinal bleeding. Dis Manage 2002; 5(3):123-35.
  • Lofland JH, Kim SS, Batenhorst AS, Johnson NE, Chatterton ML, Cady RK, Kaniecki R, Nash DB. Cost-effectiveness and cost-benefit of sumatriptan in patients with migraine. Mayo Clin Proc 2001; 76(11):1093-101.
  • Lofland JH, Locklear JC, Frick KD. Different approaches to valuing the lost productivity of patients with migraine. Pharmacoeconomics 2001; 19(9):917-25.
  • Meletiche DM, Lofland JH, Young WB. Quality-of-life differences between patients with episodic and transformed migraine. Headache 2001; 41(6):573-8.
  • Lofland JH, Schaffer M, Goldfarb N. Evaluating health-related quality of life: Cost comparison of computerized touch-screen technology and traditional paper systems. Pharmacotherapy 2000; 20(11 I):1390-5.
  • McCartney LE, Kim SS, Gevirtz F. Questionnaire development part III: A practical application. P and T 1999; 24(10):472-9.
  • Meletiche DM, Doshi D, Lofland JH. Medical outcomes study short form 36: A possible source of utilities? Clin Ther 1999; 21(11):2016-26.
  • Johnson NE, Yuran TE. In the pursuit of patient satisfaction data. P and T 1998; 23(6):311-317.
  • Doyle JJ. The role of disease management in pharmaceutical outcomes. P and T 1997; 22(6):281-5.
  • Shoheiber O, Biskupiak JE, Nash DB. Estimation of the cost savings resulting from the use of ursodiol for the prevention of gallstones in obese patients undergoing rapid weight reduction. Int J Obes 1997; 21(11):1038-45.
  • Johnson NE, Doyle JJ. A stepwise approach to performing a preliminary pharmacoeconomic analysis: Focus on fosphenytoin. P and T 1996; 21(11):611-621.